News
What's happening in Alzheimer's care, research funding, and treatment — summarized simply, each item linked to the original reporting.
Free to read, “May need a subscription” and “Archived copy”: what they mean
Whether an article is free to read is a guess, not a test of your access. Each item is one of three:
- No label: free to read (304 of 349). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
- May need a subscription (11 of 349). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
- “Free to read? Not known” (34 of 349). The outlet is on neither list and its page said nothing. We do not call these paywalled.
Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 265 of 349 items have one.
Biological clock based on blood measurements predicts mouse lifespan and frailty
NIA investigators have created a biological clock for mice based on blood measurements. Learn how the clock can help predict differences in aging and how the findings could translate to clinical practice.
Why it matters: NIA investigators created a biological clock for mice based on blood measurements that helps predict differences in aging and could translate to clinical practice.
Read at NIH National Institute on Aging → Archived copy (2 Aug 2026), Internet ArchiveNIA statement on the U.S. Cost of Dementia Model report
Read an announcement about an NIA-funded project that reports the economic burden of Alzheimer's disease and related dementia in the United States.
Why it matters: An NIA-funded project reports the economic burden of Alzheimer's disease and related dementia in the United States.
Read at NIH National Institute on Aging → Archived copy (2 Aug 2026), Internet ArchiveA gene guiding brain cell growth may regulate Alzheimer’s plaque size and toxicity
Plexin-B1 shapes glial networks around beta-amyloid plaques. An NIA-funded study has found that targeting it may improve plaque clearance and reduce brain inflammation.
Why it matters: Targeting Plexin-B1 may improve beta-amyloid plaque clearance and reduce brain inflammation, offering a potential path to regulate Alzheimer's plaque size and toxicity.
Read at NIH National Institute on Aging → Archived copy (2 Oct 2026), Internet ArchiveNew drug candidate targeting synaptic resilience well tolerated in Alzheimer’s patients
A new drug targeting synaptic resilience shows potential in treating Alzheimer’s disease in an NIA-funded study, with early trials indicating safety and possible brain damage reduction. Further research is needed on the drug’s long-term effects.
Why it matters: An NIA-funded study shows a new Alzheimer's drug candidate targeting synaptic resilience is well tolerated in early trials and may reduce brain damage.
South Africa cash transfer program slowed cognitive decline for midlife and older adults
A modest cash-transfer intervention slowed memory decline and lowered dementia risk among midlife and older adults in rural South Africa.
Why it matters: A modest cash-transfer intervention slowed memory decline and lowered dementia risk among midlife and older adults in rural South Africa.
Read at NIH National Institute on Aging → Archived copy (30 Jul 2026), Internet ArchiveReview of Medicare data reveals potential new statistics on dementia diagnosis
A study of Medicare data showed that roughly 9% of beneficiaries — 5.3 million people — may have Alzheimer’s disease or a related dementia.
Why it matters: A review of Medicare data indicates that approximately 9 percent of beneficiaries, totaling 5.3 million people, may have Alzheimer’s disease or a related dementia.
Risk and future burden of dementia in the United States
NIA study reveals that nearly 42% of Americans over 55 may develop dementia, with new cases possibly doubling by 2060. Learn about the rising risk and future impact.
Why it matters: An NIA study reveals that nearly 42% of Americans over 55 may develop dementia, with new cases possibly doubling by 2060.
Timeframe of 8-hour restricted eating irrelevant to weight loss
European adults with obesity who limited eating to any of three 8-hour window timeframes each day lost weight and improved cardiometabolic health.
Why it matters: European adults with obesity lost weight and improved cardiometabolic health when limiting eating to any of three 8-hour window timeframes each day.
Read at NIH National Institute on Aging → Archived copy (1 Aug 2026), Internet ArchiveA mother’s X chromosome affects learning and memory in later life
A mother’s X chromosomes may turn off key genes, accelerate brain cell aging process, and impair learning and memory later in life.
Why it matters: A mother's X chromosomes may accelerate brain cell aging and turn off key genes, impairing learning and memory in later life.
Read at NIH National Institute on Aging → Archived copy (30 Jul 2026), Internet ArchiveSenolytic therapy shows subtle impact on age-related bone health in women
An NIA-funded clinical trial investigating whether senolytics could improve bone health in older women had just subtle results.
Why it matters: An NIA-funded clinical trial investigating whether senolytics could improve bone health in older women had just subtle results.
Read at NIH National Institute on Aging → Archived copy (7 Jul 2025), Internet ArchiveScientists develop improved mouse model for studying systemic aging-related health decline
NIA scientists developed an improved mouse model to study aging-related health decline, revealing how inflammation drives organ damage.
Why it matters: NIA scientists developed an improved mouse model to study aging-related health decline, revealing how inflammation drives organ damage.
Read at NIH National Institute on Aging → Archived copy (2 Aug 2026), Internet ArchiveBright brain spots from small blood vessels could help predict Alzheimer’s risk
Bright spots in the brain called white matter hyperintensities contribute to Alzheimer’s risk. Reducing their accumulation might help slow or prevent the disease.
Why it matters: Bright spots in the brain called white matter hyperintensities contribute to Alzheimer’s risk, and reducing their accumulation might help slow or prevent the disease.
Read at NIH National Institute on Aging → Archived copy (4 Aug 2026), Internet ArchiveFollow new items in a feed reader: Atom feed.